Related references
Note: Only part of the references are listed.Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
Cecile Guichard et al.
NATURE GENETICS (2012)
Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation
F. Wang et al.
ONCOGENE (2012)
Sirtuins and disease: the road ahead
Vincenzo Carafa et al.
FRONTIERS IN PHARMACOLOGY (2012)
SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity
Hyun-Seok Kim et al.
CANCER CELL (2011)
Sirtuin 1 in malignant transformation: Friend or foe?
Yujiang Fang et al.
CANCER LETTERS (2011)
Sirtuin 1 Is Upregulated in a Subset of Hepatocellular Carcinomas where It Is Essential for Telomere Maintenance and Tumor Cell Growth
Juan Chen et al.
CANCER RESEARCH (2011)
The Deacetylase SIRT1 Promotes Membrane Localization and Activation of Akt and PDK1 During Tumorigenesis and Cardiac Hypertrophy
Nagalingam R. Sundaresan et al.
SCIENCE SIGNALING (2011)
SIRT2-mediated protein deacetylation: An emerging key regulator in brain physiology and pathology
Kai Harting et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2010)
SIRT1 contributes to telomere maintenance and augments global homologous recombination
Jose A. Palacios et al.
JOURNAL OF CELL BIOLOGY (2010)
SIRT2 regulates NF-κB-dependent gene expression through deacetylation of p65 Lys310
Karin M. Rothgiesser et al.
JOURNAL OF CELL SCIENCE (2010)
Alisol B, a Novel Inhibitor of the Sarcoplasmic/Endoplasmic Reticulum Ca2+ ATPase Pump, Induces Autophagy, Endoplasmic Reticulum Stress, and Apoptosis
Betty Y. K. Law et al.
MOLECULAR CANCER THERAPEUTICS (2010)
SIRT1 regulates Dishevelled proteins and promotes transient and constitutive Wnt signaling
Kimberly R. Holloway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Histone H3-K56 acetylation is important for genomic stability in mammals
Jian Yuan et al.
CELL CYCLE (2009)
Functional interplay between Parp-1 and SirT1 in genome integrity and chromatin-based processes
Rosy El Ramy et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease
Herve Acloque et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice
Rui-Hong Wang et al.
CANCER CELL (2008)
The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility
Ruwin Pandithage et al.
JOURNAL OF CELL BIOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth
Ron Firestein et al.
PLOS ONE (2008)
Interphase Nucleo-Cytoplasmic Shuttling and Localization of SIRT2 during Mitosis
Brian J. North et al.
PLOS ONE (2007)
SIRT1 is significantly elevated in mouse and human prostate cancer
Derek M. Huffman et al.
CANCER RESEARCH (2007)
Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation
Brian J. North et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Sirtuins in mammals: insights into their biological function
Shaday Michan et al.
BIOCHEMICAL JOURNAL (2007)
Strong expression of a longevity-related protein, SIRT1, in Bowen's disease
Yasutoshi Hida et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2007)
A Wnt-Axin2-GSK3β cascade regulates Snail1 activity in breast cancer cells
Jong In Yook et al.
NATURE CELL BIOLOGY (2006)
Mammalian sirtuins - emerging roles in physiology, aging, and calorie restriction
Marcia C. Haigis et al.
GENES & DEVELOPMENT (2006)
Treatment of hepatocellular carcinoma
Alejandro Forner et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis
Alejandro Vaquero et al.
GENES & DEVELOPMENT (2006)
Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes
B Heltweg et al.
CANCER RESEARCH (2006)
Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (sirtuin) inhibitors
A Mai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
A randomized phase III study of doxorubicin versus cisplatin/interferon α-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma
W Yeo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors
C Bradbury et al.
LEUKEMIA (2005)
The Sir2 family of protein deacetylases
G Blander et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition
BHP Zhou et al.
NATURE CELL BIOLOGY (2004)
Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene
M Hiratsuka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle
SC Dryden et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Identification of a small molecule inhibitor of Sir2p
A Bedalov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Akt participation in the Wnt signaling pathway through dishevelled
S Fukumoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
S Imai et al.
NATURE (2000)
Share Paper
